(Q43292977)

English

An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia

scientific article published on 11 August 2009

Statements

An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit